Navigation Links
Utilizing Public Relation Strategies During Pharmaceutical Lifecycle Management for Greatest Impact on Brand and Consumer Base
Date:12/12/2011

CHAPEL HILL, N.C., Dec. 12, 2011 /PRNewswire/ -- Public Relations tactics and tools are broad-reaching, affecting millions of consumers when successful. This makes Public Relations a highly leveraged marketing investment, requiring relatively low investment to reach large audiences. More specifically, Public Relations tools can be easily utilized to benefit all phases of the product lifecycle, especially at launch and brand-building years.

However, field research suggests few companies maximize the full potential of PR campaigns throughout the entire product lifecycle – from preparing and launching to growing and extending a brand, according to Best Practices, LLC study, "Using Public Relations to Launch, Grow and Extend Your Brands."

While Public Relations have long been used as a marketing tool by the pharmaceutical and biotechnology industries, its ability to reach consumers has never been greater. This research will help companies take advantage of the many recommendations and actions to better align PR activities and tactics during the different stages of a product's lifecycle.

Public Relations can also help build a bridge from between a first-generation success to a future blockbuster. Field findings revealed that successor product teams generally should commence Public Relations two years prior to the new product's global launch.

Study topics include:

  • Public relations tools and tactics that are most effective at different lifecycle stages
  • The most effective public relations tools and calls-to-action
  • Successful web site resources for consumers
  • Ideal budget ratios and performance measurements
  • Lessons learned and best practices

The full 108-page report contains over
'/>"/>

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
2. New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis
3. nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure
4. Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
5. Life Spine® Announces Completion of Surgeries Utilizing OCTAVE™ Posterior Fusion System
6. iCyt Unveils Exciting New Flow Cytometry Reagents Utilizing Innovative Fluorochrome Technology
7. Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT®
8. Ambry Genetics Announces Launch of Their CancerArray™ Product and Services Utilizing aCGH Technology
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
11. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... --  BioNano Genomics announced today achievement of a major ... data at 30X depth, sufficient for a genome map, in ... established and demonstrated for the IrysChip TM V2, the ... and will be rolled out to BioNano,s collaborators and customers ... advancement at the American Society for Human Genetics (ASHG) ...
(Date:10/20/2014)... 2014 Lpath, Inc. (NASDAQ: ... therapeutics, received official notification from the European Patent Office ... patent supporting its iSONEP™ and ASONEP™ programs. ... No. 2087002, claims compositions of matter related to ... compounds, iSONEP and ASONEP. Sonepcizumab is an antibody ...
(Date:10/20/2014)... 2014 Norgine B.V. today announced ... volume bowel preparation, NER1006, presented at the 79 th ... Gastroenterology (ACG), Philadelphia, PA , has ... and co-primary endpoint of cleansing success. The study demonstrated ... ® in screening colonoscopy patients. [1] ...
Breaking Medicine Technology:BioNano Genomics Announces One Human : One Chip : One Day 2BioNano Genomics Announces One Human : One Chip : One Day 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2
... 13, 2011 BD (Becton, Dickinson and Company) (NYSE: ... a subsidiary of Waste Management, Inc. (NYSE: ... sharps waste from hospitals and other healthcare facilities.  The ... Solution, an innovative service that will recycle medical sharps ...
... Healthcare Financial Management Association (HFMA) has recognized the ... ("SIS") as once again consistently meeting the "Peer ... offerings as part of the annual evaluation process ... HFMA Peer Reviewed designation.  ...
Cached Medicine Technology:BD and Waste Management Launch Initiative to Recycle Medical Sharps 2BD and Waste Management Launch Initiative to Recycle Medical Sharps 3BD and Waste Management Launch Initiative to Recycle Medical Sharps 4Surgical Information Systems Renews HFMA Peer Review Designation for Fourth Consecutive Year 2Surgical Information Systems Renews HFMA Peer Review Designation for Fourth Consecutive Year 3
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Principle ... years, takes pride in manufacturing top-of-the-line absorbent products. ... image of its most popular brand, Tranquility® Premium Protection ... created a new website, gave its packaging a new ... bring the brand message to the public. , The ...
(Date:10/20/2014)... Norristown, PA (PRWEB) October 20, 2014 ... of Matthew Voicheck as Assistant Director of their ... integral role in managing the innovative turnkey drug ... trials. , Matthew brings over 12 years of ... He joins Myoderm at the peak of their ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Succeed is proud ... local companies who participated in the Every Body Walk! ... a public awareness project that encourages workers to be more ... Step 10,000 Program, which concluded at the end of September, ... of cities and metro areas. Participating companies gave their ...
(Date:10/20/2014)... National Teen Driver Safety Week is October 19-25, 2014 and ... AAP, http://www.ohioaap.org ) is joining the National Highway Traffic ... talk to their teens and always set the rules before ... leading cause of death for U.S. teens. In 2012, there ... (42%) of those teen drivers were killed in crashes. While ...
(Date:10/20/2014)... 2014 Unveiled at the Sept. 18 board ... conservatively estimates member hospital ROI on membership dues at 12.5. ... Center provides $12.50 in value to member hospitals. The calculation ... Member Dues)/Member Dues. , “This is the first time ... we think the methodology is really sound,” said Bill ...
Breaking Medicine News(10 mins):Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4
... Medical College at Dallas report that contact lenses, ... transmissible materials are expected to reduce the possibility ... are available now. Based in part on these ... approved hyper-oxygen transmissible contact lenses for 30-day continuous ...
... offers the hope of a less painful technique than traditional ... into an artery to bypass a blockage in the heart ... redirecting traffic. The blood is sent to the heart muscle ... ,Dr Stephen Oesterle, the author of a report into the ...
... has been experimented that can suppress menstruation for as long ... years.The tablet, which blocks the action of the hormone progesterone, ... the monthly menstrual cycle. Two versions of the new pill ... results published by American and German scientists in the latest ...
... for persons suffering from types of hereditary cancers.The Imperial ... allow doctors to identify people likely to suffer from ... ,By looking at skin warts, benign growths ... a history of HNPCC //- hereditary non-polyposis colorectal cancer ...
... detect cervical cancer,has been developed by Australians which may replace ... UK, Italy, Spain as well as Australia. ,Sydney-based Polartechnics ... CSIRO and claims that it offers instant results and greater ... probe to collect information directly from the cervix about the ...
... see couples who are HIV sero discordant but who would like ... and the wife is negative and they are planning to have ... in 500 risk of transmitting the virus to the female partner ... Sperm washing is a risk-reduction option in which ...
Cached Medicine News:Health News:New contact lens materials 2Health News:Revolution in surgery 2Health News:Pause as you please 2Health News:Sperm washing helps couples 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: